The Male Sexual Dysfunction drugs in development market research report provides comprehensive information on the therapeutics under development for Male Sexual Dysfunction, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA), and molecule type. GlobalData’s report assesses key aspects of the companies and drugs in development for Male Sexual Dysfunction. Buy the report here.
Smarter leaders trust GlobalData
The report also covers the descriptive pharmacological action of the therapeutics and the latest news and press releases. Additionally, the report provides an overview of the key players involved in therapeutic development for Male Sexual Dysfunction and features dormant and discontinued products.
GlobalData tracks two drugs in development for Male Sexual Dysfunction by one companies/universities/institutes. The top development phase for Male Sexual Dysfunction is phase ii with two drugs in that stage. The Male Sexual Dysfunction pipeline has two drugs in development by companies and 0 by universities/ institutes. Some of the companies in the Male Sexual Dysfunction pipeline products market are: Thomas Advanced Medical.
The key mechanisms of action in the Male Sexual Dysfunction pipeline product include The Male Sexual Dysfunction pipeline products include four routes of administration with the top ROA being Intramuscular and one key molecule types in the Male Sexual Dysfunction pipeline products market including Cell Therapy.
Male Sexual Dysfunction overview
Male sexual dysfunction encompasses a range of difficulties that can affect a man’s ability to engage in sexual activity or experience satisfaction from sexual activity. It can manifest in various forms and can be caused by physical, psychological, or relational factors. Erectile dysfunction (ED) is one of the most common, characterized by the inability to achieve or maintain an erection firm enough for satisfactory sexual performance. Causes can include underlying health conditions like diabetes or hypertension, psychological factors (stress, anxiety), hormonal imbalances, or lifestyle factors (smoking, obesity). Premature ejaculation (PE) occurs when a man ejaculates sooner than desired during sexual activity, often with minimal stimulation. It can lead to distress or frustration for both partners. Causes may involve psychological factors, relationship issues, or hypersensitivity of the penis. Delayed ejaculation refers to the difficulty or inability to reach orgasm or ejaculate, even with sufficient sexual stimulation. It may be associated with physical factors, such as nerve damage or medication side effects, as well as psychological or emotional factors. Low libido (hypoactive sexual desire disorder) involves a decreased interest or desire for sexual activity that causes distress or relationship issues. Low libido can result from hormonal imbalances, stress, relationship problems, depression, or certain medications.
For a complete picture of Male Sexual Dysfunction’s pipeline drug market, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
GlobalData’s pipeline drugs offers detailed profiles of pharmaceutical drugs in all stages of pre-clinical and clinical development, from discovery through to pre-registration. Coverage is limited to novel human medicinal drugs and biosimilars seeking market approval proprietary and is one of two primary repositories of pharmaceutical drug information offered by GlobalData through its Pharmaceutical Intelligence Center.
